Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000247227

Medchemexpress LLC 5-chloro-2-fluoro-4-(hexahydropyrrolizin-8-ylmethylamino)-N-(thiazol-2-yl)benzenesulfonamide | 1788872-06-9 | 98.2% | 430.95 g/mol | C17H20ClFN4O2S2 | 10 MG
SDP

Catalog No. 5000247227
Encompass_Preferred

Nav1.7-IN-3 is a selective, orally bioavailable small-molecule inhibitor of the voltage-gated sodium channel Nav1.7 with a reported IC50 of 8 nM. The compound shows limited central nervous system penetration and is supplied for laboratory research (CAS 1788872-06-9).

  • Selective Nav1.7 inhibition (IC50 = 8 nM).
  • Orally bioavailable.
  • Limited CNS penetration.
  • High purity (~98.2%).
  • Molecular weight 430.95 g/mol; formula C17H20ClFN4O2S2.
  • Provided in small research quantities (e.g., 10 MG).

Catalog No. 50-002-47227 Supplier Medchemexpress LLC Supplier No. HY10178910MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nav1.7-IN-3 is a selective, orally bioavailable small-molecule inhibitor of the voltage-gated sodium channel Nav1.7 with a reported IC50 of 8 nM. The compound shows limited central nervous system penetration and is supplied for laboratory research (CAS 1788872-06-9).

  • Selective Nav1.7 inhibition (IC50 = 8 nM).
  • Orally bioavailable.
  • Limited CNS penetration.
  • High purity (~98.2%).
  • Molecular weight 430.95 g/mol; formula C17H20ClFN4O2S2.
  • Provided in small research quantities (e.g., 10 MG).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.